PRMRP-Norms: Iterative Design of Custom Dynamic Orthoses

Sponsor
University of Iowa (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04800510
Collaborator
(none)
9
1
4
32.3
0.3

Study Details

Study Description

Brief Summary

The proposed study evaluates the effect of carbon fiber brace design on forces across the ankle joint. It is expected that carbon fiber braces can be designed to reduce forces in the ankle. In this study, brace geometry will be varied to determine how these changes influence the forces experienced by ankle cartilage. The purpose of this study is to refine a pre-existing musculoskeletal model and finalize the procedures for inputting multiple data sources into the model to evaluate ankle articular contact stresses.

Condition or Disease Intervention/Treatment Phase
  • Device: Carbon Fiber Custom Dynamic Orthosis (CDO)
N/A

Detailed Description

The purpose of this study is to refine a pre-existing musculoskeletal model and finalize the procedures for inputting multiple data sources into the model to evaluate ankle articular contact stresses.

Healthy adult participants will complete testing using three generic sized carbon fiber custom dynamic orthoses (CDOs) and with no CDO. Participants will be blinded to the design variation of each device and will only know them as CDO-A, CDO-B, or CDO-C. Testing will be completed under 4 conditions: No-CDO, CDO-A, CDO-B, CDO-C, with each bracing condition (A/B/C) representing a CDO design variant. Physical performance measures will incorporate tests of agility, speed, and lower limb power to ensure that changes to device design do not negatively affect physical function. Questionnaires will be used to evaluate participants' current and desired activity level, pain with and without CDO use, satisfaction with the devices, perception of comfort and smoothness between devices, and preference between CDOs. Semi-structured interviews will be completed to fully capture the participant's perspective. Lower limb forces and motion will be assessed using a computerized motion capture system and force plates in the floor. Forces between the foot and CDO will be measured using force sensing insoles, and muscle activity data will be collected using surface electromyography. Devices will be mechanically tested, and participant demographic and anthropometric data will be recorded.

The information obtained from this study will help refine the musculoskeletal model data input methods to be used in future studies. The knowledge that will be gained from this investigation has the potential to substantially improve the long-term efficacy and efficiency of the musculoskeletal model and help improve ankle foot orthosis

Study Design

Study Type:
Interventional
Actual Enrollment :
9 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
All participants will use three generic sized carbon fiber custom dynamic orthoses (CDOs). Each CDO will differ from the others in design and will be labeled as CDO-A, CDO-B and CDO-C. Participants will be randomly assigned to one of six CDO testing sequences (ABC, ACB, BCA, BAC, CAB, CBA) to prevent testing order from influencing study results.All participants will use three generic sized carbon fiber custom dynamic orthoses (CDOs). Each CDO will differ from the others in design and will be labeled as CDO-A, CDO-B and CDO-C. Participants will be randomly assigned to one of six CDO testing sequences (ABC, ACB, BCA, BAC, CAB, CBA) to prevent testing order from influencing study results.
Masking:
Single (Participant)
Masking Description:
Participants will be blinded to the different design variations of each device, and will only be introduced to each device as CDO-A, CDO-B or CDO-C.
Primary Purpose:
Other
Official Title:
Iterative Design of Custom Dynamic Orthoses and Comprehensive Design of Musculoskeletal Model
Actual Study Start Date :
Apr 21, 2021
Actual Primary Completion Date :
Jun 25, 2022
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: NoCDO

Participants will be evaluated without a CDO.

Experimental: CDO-A

The first design variant will be designated CDO-A.

Device: Carbon Fiber Custom Dynamic Orthosis (CDO)
The CDO will consist of a semi-rigid foot plate, a posterior carbon fiber strut, and a proximal cuff below the knee.
Other Names:
  • Ankle Foot Orthosis
  • Experimental: CDO-B

    The second design variant will be designated CDO-B.

    Device: Carbon Fiber Custom Dynamic Orthosis (CDO)
    The CDO will consist of a semi-rigid foot plate, a posterior carbon fiber strut, and a proximal cuff below the knee.
    Other Names:
  • Ankle Foot Orthosis
  • Experimental: CDO-C

    The third design variant will be designated CDO-C.

    Device: Carbon Fiber Custom Dynamic Orthosis (CDO)
    The CDO will consist of a semi-rigid foot plate, a posterior carbon fiber strut, and a proximal cuff below the knee.
    Other Names:
  • Ankle Foot Orthosis
  • Outcome Measures

    Primary Outcome Measures

    1. Joint Contact Stress Exposure (Model estimated) [Baseline]

      Joint contact stress exposure (MPA-s/gait cycle) will be estimated using a participant specific musculoskeletal model.

    Secondary Outcome Measures

    1. Four Square Step Test (4SST) [Baseline]

      The 4SST (s) is a standardized timed test of balance and agility.

    2. Sit to Stand 5 Times (STS5) [Baseline]

      STS5 (s) is a well-established timed measure of lower limb muscle strength and power. Participants are instructed to stand up and sit down 5 times as fast as possible.

    3. Ankle Range of Motion [Baseline]

      Ankle range of motion (degrees) during gait.

    4. Peak Ankle Moment [Baseline]

      Peak ankle moment (Nm/kg) during gait.

    5. Peak Ankle Power [Baseline]

      Peak ankle power (W/kg) during gait.

    6. Center of pressure velocity timing [Baseline]

      Timing of peak center of pressure velocity (percent stance) during gait.

    7. Center of pressure velocity magnitude [Baseline]

      Magnitude of peak center of pressure velocity (m/s) during gait.

    8. Soleus Muscle Activity (Electromyography) [Baseline]

      Electromyography (EMG, % Maximum) of the Soleus during gait.

    9. Tibialis Anterior Muscle Activity (Electromyography) [Baseline]

      Electromyography (EMG, % Maximum) of the Tibialis Anterior during gait.

    10. Medial Gastrocnemius Muscle Activity (Electromyography) [Baseline]

      Electromyography (EMG, % Maximum) of the Medial Gastrocnemius during gait.

    11. Rectus Femoris Muscle Activity (Electromyography) [Baseline]

      Electromyography (EMG, % Maximum) of the Rectus Femoris during gait.

    12. Vastus Medialis Muscle Activity (Electromyography) [Baseline]

      Electromyography (EMG, % Maximum) of the Vastus Medialis during gait.

    13. Plantar Force [Baseline]

      Force data (N) collected from the hind foot, mid foot, and forefoot, measured between the foot and orthosis during gait.

    Other Outcome Measures

    1. The Orthotics Prosthetics Users' Survey (OPUS) [Baseline]

      Satisfaction with device will be assessed using the Orthotics Prosthetics Users' Survey Satisfaction With Device Score (11-55). Lower scores indicate a better outcome.

    2. Modified Socket Comfort Score (Comfort and Smoothness) [Baseline]

      Comfort scores range from 0 = most uncomfortable to 10 = most comfortable, and from 0 = least smooth to 10 = most smooth.

    3. Numerical Pain Rating Scale [Baseline]

      Pain will be assessed using a standard 11-point numerical pain rating scale, in which 0 = no pain and 10 = worst pain imaginable.

    4. Participant Device Preference [Baseline]

      The participant will rank order their preference for their standard of care device (if applicable), No Device, CDO-A, CDO-B, CDO-C on a questionnaire.

    5. Semi-Structured Interview [Baseline]

      Semi-structured interviews will also be used to fully capture the patients' perspectives, experience, and opinions associated with the device options they experienced as part of the study.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Between the ages of 18 and 50

    • Shoe size between women's 8 and 13.5 or men's 6.5 and 12

    • Healthy individuals without a current complaint of lower extremity pain, spine pain, or medical or neuromusculoskeletal disorders that have limited participation in work or exercise in the last 6 months

    • Full active range of motion of the bilateral lower extremities and spine

    • Ability to hop without pain

    • Ability to perform a full squat without pain

    • Ability to read and write in English and provide written informed consent

    Exclusion Criteria:
    • Diagnosed moderate or severe brain injury

    • Prior lower extremity injury resulting in surgery or limiting function for greater than 6 weeks

    • Diagnosis of a physical or psychological condition that would preclude testing (e.g. cardiac condition, clotting disorder, pulmonary condition)

    • Visual or hearing impairment that would interfere with instructions given during testing

    • Require an assistive device

    • Wounds to the foot or calf that would prevent CDO use

    • BMI greater than 35

    • Pregnancy - Per participant self-report. Due to the expected small number of pregnant individuals and resulting inability to account for its effect on resulting outcomes, participants will be withdrawn from the study

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The University of Iowa Iowa City Iowa United States 52242

    Sponsors and Collaborators

    • University of Iowa

    Investigators

    • Principal Investigator: Jason M Wilken, PT, PhD, University of Iowa

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jason Wilken, Associate Professor, University of Iowa
    ClinicalTrials.gov Identifier:
    NCT04800510
    Other Study ID Numbers:
    • 202002131
    First Posted:
    Mar 16, 2021
    Last Update Posted:
    Jul 13, 2022
    Last Verified:
    Jul 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Jason Wilken, Associate Professor, University of Iowa
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 13, 2022